Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-K stay in one workspace.
NXTC
$4.98
+5.51%
NXTC
· NextCure, Inc.
$4.98
+0.26 (+5.51%)
At close · Oct 23
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 6, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Our expectation to incur additional operating losses and negative operating cash flows in the future and the need for additional funding to support our planned operations raise substantial doubt regarding our ability to continue as a going concern for a period of one year after the date that these unaudited financial statements are issued.”View the 10-Q filed Aug 6, 2026
Market Cap
$21.61M
Shares
4.58M
Volume · Oct 23
48.55K
Avg daily vol (3M)
189.6K
All webcasts
Earnings call · FY2020 Q4
NextCure, Inc. (NXTC) Q4 2020 Earnings Call
Net income · derived Q4
-$15.46M
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Mar 4, 2021 · complete as-filed document
SEC periodic report
10-K report
Filed Apr 26, 2021 · complete as-filed document